Manager, Artwork and Label Engineer at Bristol-Myers Squibb

Seattle, Washington, United States

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, BiotechnologyIndustries

Requirements

BA/BS Degree with 5+ years of relevant work experience or MS degree with 2-4 years of relevant work experience
Proficiency in project management with the ability to independently plan, prioritize, schedule, and coordinate multiple projects simultaneously
Experience in a cGMP environment with a track record of managing multiple quality records
Knowledge of packaging, labeling, and printing technologies
Excellent attention to detail with focus on product quality
Comfortable working with Excel, Visio, SharePoint and any other electronic systems used in creation of label proof and artwork
Basic knowledge of functional areas and drug development process

Responsibilities

Manage artwork for clinical and commercial printed materials for cGMP use
Support life cycle management changes of L&P components
Coordinate with artwork and label vendors to ensure key project milestones are met
Identify gaps in the process and update policies/procedures as necessary
Proactively mitigate and communicate issues between relevant functional areas
Support Cell Therapy manufacturing sites in L&P related packaging deviations and investigations

Skills

project management

artwork management

labeling

packaging

cGMP

life cycle management

vendor coordination

policy development

deviation investigations

cell therapy

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free